AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Dermatology Insurance Denials, Downcoding, and E&M Billing Guidance

Description

The speaker reviews dermatology billing issues, focusing on how claims move through billing companies, clearinghouses, and insurers, and why denials or downcoding occur. Medicare denials usually stem from rule violations, while private insurers and managed Medicare often apply their own rules, sometimes refusing same-day E&M and procedures or requiring documentation language that changes over time. The talk emphasizes the need for staff to review every EOB, distinguish one-off denials from systemic problems, and appeal inappropriate downcoding using the AAD’s private payer appeal letter tool. The speaker explains that dermatology is heavily scrutinized for 25 modifiers because it is a procedural and cognitive specialty, but argues that many uses are appropriate and that Medicare has largely accepted this after audits. They also discuss E&M coding basics, noting that level 2 visits are usually minor issues, level 3 acute rashes, and level 4 chronic problems; overbilling level 4 for simple self-limited conditions like poison ivy is incorrect and invites scrutiny. The talk warns against institutional practices that force E&M billing on every Mohs case or unnecessary full skin exams, since this can devalue dermatology services and trigger payer review. It concludes by urging clinicians to report only systemic payer problems to the AAD, recognize that reform is slow, and support legislative efforts in states where insurers are downcoding or refusing proper payment.

View more

Conclusions

  • Most straightforward Medicare claims and appeals can usually be corrected relatively easily, while private insurers are far more variable, opaque, and difficult to challenge.
  • Dermatologists should understand the claim-flow and denial process because many rejections come from fixable billing or documentation issues rather than true nonpayment rules.
  • When a same-day E/M service is truly separate from a minor procedure, it should be billed, but the note must clearly justify distinct decision making.
  • Medicare’s rules are comparatively standardized, but private and managed plans often impose their own policies, including denial of same-day E/M or arbitrary downcoding.
  • Downcoding appears to be widespread across multiple insurers and specialties, but most affected claims can be successfully appealed if the issue is legitimate.
  • The AAD and its advocacy tools are an important resource for systematically addressing recurring payer problems, especially when multiple physicians are affected.
  • Modifier 25 use in dermatology is generally justified and was largely supported in the OIG audit, so dermatology should not be treated as abusing it by default.
  • Billing every Mohs patient with an E/M service or inflating documentation just to preserve reimbursement is short-sighted and can ultimately weaken the specialty’s position.
  • Higher-level E/M billing should reflect real complexity, such as chronic, nonresolving problems or high-acuity care, rather than routine self-limited conditions.
  • Insurer downcoding often operates like a black box, with threshold-based or algorithmic rules that payers rarely disclose.
  • Appealing downcoded claims is worth doing because a large majority of legitimate appeals are overturned, and successful challenge can remove practices from monitoring programs.
  • The best long-term response to systemic payer behavior may be coordinated advocacy and, in some states, legislation that limits downcoding and protects modifier 25 payment.
  • OIG. Dermatologist Claims for Evaluation and Management Services on the Same Day as Minor Surgical Procedures. U.S. Department of Health and Human Services, Office of Inspector General.
  • Figure 1: Provider Specialties with Highest Modifier 25 Usage Rates During the Audit Period.
  • 2018 eGlobalTech Comparative Billing.
  • Figure 2. Proportion of visits with each level-of-service code for established patient office visits. EpicResearch.org.
  • American Academy of Dermatology | Association.
  • Current E/M Coding Tool.
  • Understanding current evaluation and management (E/M) guidelines.
  • Successful documentation tips that withstand an audit.
  • Indiana HB1271.07.ENRS.pdf.
  • American Medical Association E&M criteria.